• Filter by client profile:
  • gender |
  • age |
  • accommodation situation |
  • with whom living |
  • education status |
  • employment status |
  • new client |
  • inpatient |
  • outpatient
• Filter by drug type:
  • amphetamines|
  • cannabis |
  • cocaine |
  • ecstasy |
  • heroin |
  • hallucinogens |
  • hypnotics/sedatives |
  • volatiles |
  • 'other drugs'
• Filter by patterns of use:
  • age at first use |
  • frequency of use |
  • primary drug |
  • secondary drug |
  • route of administration

Statistics found here the category is Demand for treatment for drug use (TDI) and where the keyword is sedatives

Category	Title
TDI	TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (i) New outpatient clients, age distribution by primary drug (%)
TDI	TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (ii) New outpatient clients, primary drug distribution by age (%)
TDI	TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (iii) All outpatient clients, age distribution by primary drug (%)
TDI	TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (iv) All outpatient clients, primary drug distribution by age (%)
TDI	TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (v) New inpatient clients, age distribution by primary drug (%)
TDI	TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (vi) New inpatient clients, primary drug distribution by age (%)
TDI	TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (vii) All inpatient clients, age distribution by primary drug (%)
TDI	TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (viii) All inpatient clients, primary drug distribution by age (%)
TDI	TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (i) New outpatient clients, age at first use distribution by primary drug (%)
TDI	TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (ii) New outpatient clients, primary drug distribution by age at first use (%)
TDI	TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (iii) All outpatient clients, age at first use distribution by primary drug (%)
TDI	TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (iv) All outpatient clients, primary drug distribution by age at first use (%)
TDI	TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (v) New inpatient clients, age at first use distribution by primary drug (%)
TDI	TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (vi) New inpatient clients, primary drug distribution by age at first use (%)
TDI	TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (vii) All inpatient clients, age at first use distribution by primary drug (%)
TDI	TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available Part (viii) All inpatient clients, primary drug distribution by age at first use (%)
TDI	TDI-17. Route of administration by primary drug of clients entering treatment, 2008 or most recent year available Part (vii) New hypnotics and sedatives outpatient clients by country and usual route of administration (%)
TDI	TDI-17. Route of administration by primary drug of clients entering treatment, 2008 or most recent year available Part (viii) All hypnotics and sedatives outpatient clients by country and usual route of administration
TDI	TDI-19. Primary drug of clients entering treatment, 2008 or most recent year available Part (i) New outpatient clients by country and primary drug (%)
TDI	TDI-19. Primary drug of clients entering treatment, 2008 or most recent year available Part (ii) All outpatient clients by country and primary drug (%)
TDI	TDI-19. Primary drug of clients entering treatment, 2008 or most recent year available Part (iii) New inpatient clients by country and primary drug (%)
TDI	TDI-19. Primary drug of clients entering treatment, 2008 or most recent year available Part (iv) All inpatient clients by country and primary drug (%)
TDI	TDI-21. Gender ratio by primary drug of clients entering treatment, 2008 or most recent year available Part (i) New outpatient clients, ratio of males to females by country and primary drug
TDI	TDI-21. Gender ratio by primary drug of clients entering treatment, 2008 or most recent year available Part (ii) All outpatient clients, ratio of males to females by country and primary drug
TDI	TDI-21. Gender ratio by primary drug of clients entering treatment, 2008 or most recent year available Part (iii) New inpatient clients, ratio of males to females by country and primary drug
TDI	TDI-21. Gender ratio by primary drug of clients entering treatment, 2008 or most recent year available Part (iv) All inpatient clients, ratio of males to females by country and primary drug
TDI	TDI-22. Secondary drugs cited by clients entering treatment, 2008 or most recent year available Part (i) Outpatient units
TDI	TDI-22. Secondary drugs cited by clients entering treatment, 2008 or most recent year available Part (ii) Inpatient units
TDI	TDI-32. Mean age of clients entering treatment by primary drug and gender, 2008 or most recent year available Part (i) Outpatient clients
TDI	TDI-32. Mean age of clients entering treatment by primary drug and gender, 2008 or most recent year available Part (ii) Inpatient clients
TDI	TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2008 or most recent year available Part (iv) Outpatient clients by secondary drug and primary drug
TDI	TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2008 or most recent year available Part (v) Inpatient clients by secondary drug and primary drug
TDI	TDI-102. New clients entering outpatient treatment by primary drug and age, 2008 or most recent year available Part (v) New hypnotics and sedatives outpatient clients by country and age
TDI	TDI-103. All clients entering outpatient treatment by primary drug and age, 2008 or most recent year available Part (v) All hypnotics and sedatives outpatient clients by country and age
TDI	TDI-104. New clients entering inpatient treatment by primary drug and age, 2008 or most recent year available Part (v) New hypnotics and sedatives inpatient clients by country and age
TDI	TDI-105. All clients entering inpatient treatment by primary drug and age, 2008 or most recent year available Part (v) All hypnotics and sedatives inpatient clients by country and age
TDI	TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2008 or most recent year available Part (v) All hypnotics and sedatives outpatient clients by country and age at first use
TDI	TDI-108. New clients entering inpatient treatment by primary drug and age at first use, 2008 or most recent year available Part (v) New hypnotics and sedatives inpatient clients by country and age at first use
TDI	TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2008 or most recent year available Part (v) All hypnotics and sedatives inpatient clients by country and age at first use